BridgeMD
New treatment option for Metabolic Adaptation to High-Intensity Interval Training
Official title Rehabilitation With Exercise-Based Intervention for Nonalcoholic Chronic Hepatic Esteatosis
ClinicalTrials.gov ID: NCT07552727
What this study is testing
- What it's testing
- This study proposes a single-blind randomized clinical trial designed to evaluate the effects of high-intensity interval training (HIIT) on liver health in adults with overweight or obesity, while also assessing the usefulness of FibroScan as a tool for detecting and monitoring hepatic changes. The study is grounded in the idea that HIIT may improve liver status in individuals with metabolic dysfunction-associated steatotic liver disease, even in the absence of major weight loss, and that FibroScan could serve not only as a diagnostic method but also as a follow-up instrument during conservative treatment.
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59
You may be able to join if
- 18 to 59 years from the Los Ríos Region
- Overweight or obesity (BMI \>25 kg/m²)
- Diagnosis of a chronic noncommunicable disease such as insulin resistance, and type 2 diabetes
- Fit to perform physical activity/exercise
- Exercise readiness will be confirmed using the PAR-Q+ questionnaire
You likely can't join if
- Excessive alcohol consumption
- Liver diseases of other etiologies
- Musculoskeletal and/or cardiovascular conditions that contraindicate exercise - Inability to attend in-person exercise sessions, or pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Valdivia, Los Ríos Region, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valdivia, Los Ríos Region, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.